InvestorsHub Logo
Replies to #23200 on Biotech Values
icon url

vieuxblue

02/04/06 11:45 AM

#23203 RE: Biowatch #23200

OT:Generics: I don't understand why they don't add more staff to the generics division at the FDA, but their hands may be tied.

You bet their hands are tied--by the lobbyists for MRK, PFE, etc.
icon url

midastouch017

02/05/06 2:22 AM

#23217 RE: Biowatch #23200

< don't understand why they don't add more staff to the generics division at the FDA>

Sheer favourism towards big Pharma, imo:
<"The branded industry has to be delighted by this backlog," said Jake Hansen, vice president for government affairs for Barr Laboratories Inc., a maker of generic drugs.>

A 'natural & given' situation, Israel probably acting in
a similar manner in its favourism towards TEVA.

I have made this claim long ago on the TEVA board and
Israel Healthcare board as well.

Dubi